These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36198087)

  • 1. Trajectory of left ventricular ejection fraction in response to therapies in patients with muscular dystrophy.
    Nikhanj A; Kashyap N; Wang K; Phan CL; Siddiqi ZA; Becher H; Oudit GY
    Echocardiography; 2022 Oct; 39(10):1328-1337. PubMed ID: 36198087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
    Bourke JP; Bueser T; Quinlivan R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009068. PubMed ID: 30326162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Intervention Improves Heart Disease and Clinical Outcomes in Patients With Muscular Dystrophy in a Multidisciplinary Care Setting.
    Nikhanj A; Yogasundaram H; Miskew Nichols B; Richman-Eisenstat J; Phan C; Bakal JA; Siddiqi ZA; Oudit GY
    J Am Heart Assoc; 2020 Jan; 9(2):e014004. PubMed ID: 31931688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Utility of Cardiovascular Magnetic Resonance-Based Phenotyping in Patients With Muscular Dystrophy.
    Kashyap N; Nikhanj A; Labib D; Prosia E; Rivest S; Flewitt J; Pfeffer G; Bakal JA; Siddiqi ZA; Coulden RA; Thompson R; White JA; Oudit GY
    J Am Heart Assoc; 2023 Nov; 12(21):e030229. PubMed ID: 37929714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between cardiac involvement and long-term clinical outcomes in patients with Duchenne muscular dystrophy.
    Cha JJ; Kim IS; Kim JY; Choi EY; Min PK; Yoon YW; Lee BK; Hong BK; Kwon HM; Cho HE; Choi WA; Kang SW; Rim SJ
    ESC Heart Fail; 2022 Aug; 9(4):2199-2206. PubMed ID: 35579098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy.
    Singh JP; Solomon SD; Fradley MG; Barac A; Kremer KA; Beck CA; Brown MW; McNitt S; Schleede S; Zareba W; Goldenberg I; Kutyifa V;
    JAMA; 2019 Nov; 322(18):1799-1805. PubMed ID: 31714987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular function in adults with muscular dystrophies: genotype-phenotype correlations.
    Martins E; Silva-Cardoso J; Silveira F; Nadais G; Gonçalves FR
    Rev Port Cardiol; 2005 Jan; 24(1):23-35. PubMed ID: 15773664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grading of Left Ventricular Diastolic Dysfunction with Preserved Systolic Function by the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging Recommendations Contributes to Predicting Cardiovascular Events in Hemodialysis Patients.
    Toida T; Toida R; Yamashita R; Komiya N; Uezono S; Komatsu H; Ishikawa T; Kitamura K; Sato Y; Fujimoto S
    Cardiorenal Med; 2019; 9(3):190-200. PubMed ID: 30844787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial intelligence calculated global longitudinal strain and left ventricular ejection fraction predicts cardiac events and all-cause mortality in patients with chest pain.
    O'Driscoll JM; Tuttolomondo D; Gaibazzi N
    Echocardiography; 2023 Dec; 40(12):1356-1364. PubMed ID: 37964624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined assessment of left ventricular end-diastolic pressure and ejection fraction by left ventriculography predicts long-term outcomes of patients with ST-segment elevation myocardial infarction.
    Saito D; Nakanishi R; Watanabe I; Yabe T; Okubo R; Amano H; Toda M; Ikeda T
    Heart Vessels; 2018 May; 33(5):453-461. PubMed ID: 29143103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study.
    Kim EK; Lee GY; Jang SY; Chang SA; Kim SM; Park SJ; Choi JO; Park SW; Choe YH; Lee SC; Oh JK
    Korean J Radiol; 2021 Mar; 22(3):324-333. PubMed ID: 32932562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines.
    Mousavi N; Tan TC; Ali M; Halpern EF; Wang L; Scherrer-Crosbie M
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):977-84. PubMed ID: 25925220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic and clinical markers of left ventricular ejection fraction and moderate or greater systolic dysfunction in left ventricular noncompaction cardiomyopathy.
    Arenas IA; Mihos CG; DeFaria Yeh D; Yucel E; Elmahdy HM; Santana O
    Echocardiography; 2018 Jul; 35(7):941-948. PubMed ID: 29577407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and risk stratification in cardiac sarcoidosis patients with preserved left ventricular ejection fraction.
    Chiba T; Nakano M; Hasebe Y; Kimura Y; Fukasawa K; Miki K; Morosawa S; Takanami K; Ota H; Fukuda K; Shimokawa H
    J Cardiol; 2020 Jan; 75(1):34-41. PubMed ID: 31277963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction.
    Citro R; Radano I; Parodi G; Di Vece D; Zito C; Novo G; Provenza G; Bellino M; Prota C; Silverio A; Antonini-Canterin F; Rigo F; Vriz O; Galasso G; Bossone E; Salerno-Uriarte J; Piscione F
    Eur J Heart Fail; 2019 Jun; 21(6):781-789. PubMed ID: 30714660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
    Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
    Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and implications of early left ventricular ejection fraction improvement in new-onset idiopathic nonischemic cardiomyopathy with narrow QRS complex: A NEOLITH substudy.
    Wang NC; Adelstein EC; Jain SK; Mendenhall GS; Shalaby AA; Voigt AH; Saba S
    Ann Noninvasive Electrocardiol; 2017 Nov; 22(6):. PubMed ID: 28497865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction.
    Hensen LCR; Goossens K; Delgado V; Abou R; Rotmans JI; Jukema JW; Bax JJ
    Eur J Heart Fail; 2018 Mar; 20(3):560-568. PubMed ID: 29164753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.
    Albert J; Lezius S; Störk S; Morbach C; Güder G; Frantz S; Wegscheider K; Ertl G; Angermann CE
    J Am Heart Assoc; 2021 Feb; 10(3):e017822. PubMed ID: 33496189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.